|
1
|
Womer KL, Vella JP and Sayegh MH: Chronic
allograft dysfunction: Mechanisms and new approaches to therapy.
Semin Nephrol. 20:126–147. 2000.PubMed/NCBI
|
|
2
|
Hernandez-Fuentes MP and Lechler RI:
Chronic graft loss. Immunological and non-immunological factors.
Contrib Nephrol. 146:54–64. 2005.PubMed/NCBI
|
|
3
|
Divakar D, Bailey RR, Frampton CM, George
PM, Walmsley TA and Murphy J: Hyperlipidemia in stable renal
transplant recipients. Nephron. 59:423–428. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roodnat JI, Mulder PG, Zietse R,
Rischen-Vos J, van Riemsdijk IC, IJzermans JN and Weimar W:
Cholesterol as an independent predictor of outcome after renal
transplantation. Transplantation. 69:1704–1710. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Serón D, Moreso F, Ramón JM, Hueso M,
Condom E, Fulladosa X, Bover J, Gil-Vernet S, Castelao AM, Alsina J
and Grinyó JM: Protocol renal allograft biopsies and the design of
clinical trials aimed to prevent or treat chronic allograft
nephropathy. Transplantation. 69:1849–1855. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wissing KM, Abramowicz D, Broeders N and
Vereerstraeten P: Hypercholesterolemia is associated with increased
kidney graft loss caused by chronic rejection in male patients with
previous acute rejection. Transplantation. 70:464–472. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Friemann S, Feuring E, Padberg W and Ernst
W: Improvement of nephrotoxicity, hypertension, and lipid
metabolism after conversion of kidney transplant recipients from
cyclosporine to tacrolimus. Transplant Proc. 30:1240–1242. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vela CG, Cristol JP, Descomps B and Mourad
G: Prospective study of lipid disorders in FK506-versus
cyclosporine-treated renal transplant patients. Transplant Proc.
32:3982000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ruan XZ, Varghese Z, Fernando R and
Moorhead JF: Cytokine regulation of low-density lipoprotein
receptor gene transcription in human mesangial cells. Nephrol Dial
Transplant. 13:1391–1397. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen M, Masaki T and Sawamura T: LOX-1,
the receptor for oxidized low-density lipoprotein identified from
endothelial cells: Implications in endothelial dysfunction and
atherosclerosis. Pharmacol Ther. 95:89–100. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shihab FS, Bennett WM, Tanner AM and Andoh
TF: Mechanism of fibrosis in experimental tacrolimus
nephrotoxicity. Transplantation. 64:1829–1837. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khanna AK and Pieper GM: NADPH oxidase
subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced
nephrotoxicity in a rat renal transplant model. Nephrol Dial
Transplant. 22:376–385. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kobashigawa JA and Kasiske BL:
Hyperlipidemia in solid organ transplantation. Transplantation.
63:331–338. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheung CY, Wong KM, Chan HW, Liu YL, Chan
YH, Wong HS, Chak WL, Cho KS, Chau KF and Li CS: Paired kidney
analysis of tacrolimus and cyclosporine microemulsion-based therapy
in Chinese cadaveric renal transplant recipients. Transpl Int.
19:657–666. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ekberg H, Bernasconi C, Tedesco-Silva H,
Vitko S, Hugo C, Demirbas A, Acevedo RR, Grinyó J, Frei U,
Vanrenterghem Y, et al: Calcineurin inhibitor minimization in the
Symphony study: Observational results 3 years after
transplantation. Am J Transplant. 9:1876–1885. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li HY, Li B, Wei YG, Yan LN, Wen TF, Zhao
JC, Xu MQ, Wang WT, Ma YK and Yang JY: Higher tacrolimus blood
concentration is related to hyperlipidemia in living donor liver
transplantation recipients. Dig Dis Sci. 57:204–209. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Racusen LC, Halloran PF and Solez K: Banff
2003 meeting report: New diagnostic insights and standards. Am J
Transplant. 4:1562–1566. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mango R, Clementi F, Borgiani P, Forleo
GB, Federici M, Contino G, Giardina E, Garza L, Fahdi IE, Lauro R,
et al: Association of single nucleotide polymorphisms in the
oxidised LDL receptor 1 (OLR1) gene in patients with acute
myocardial infarction. J Med Genet. 40:933–936. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dimény E, Fellström B, Larsson E, Tufveson
G and Lithell H: Hyperlipoproteinemia in renal transplant
recipients: Is there a linkage with chronic vascular rejection?
Transplant Proc. 25:2065–2066. 1993.PubMed/NCBI
|
|
21
|
Dimény E, Wahlberg J, Lithell H and
Fellström B: Hyperlipidaemia in renal transplantation-risk factor
for long-term graft outcome. Eur J Clin Invest. 25:574–583. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sawamura T, Kume N, Aoyama T, Moriwaki H,
Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T and Masaki
T: An endothelial receptor for oxidized low-density lipoprotein.
Nature. 386:73–77. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen M, Kakutani M, Minami M, Kataoka H,
Kume N, Narumiya S, Kita T, Masaki T and Sawamura T: Increased
expression of lectin-like oxidized low density lipoprotein
receptor-1 in initial atherosclerotic lesions of Watanabe heritable
hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol.
20:1107–1115. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kataoka H, Kume N, Miyamoto S, Minami M,
Moriwaki H, Murase T, Sawamura T, Masaki T, Hashimoto N and Kita T:
Expression of lectinlike oxidized low-density lipoprotein
receptor-1 in human atherosclerotic lesions. Circulation.
99:3110–3117. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Draude G, Hrboticky N and Lorenz RL: The
expression of the lectin-like oxidized low-density lipoprotein
receptor (LOX-1) on human vascular smooth muscle cells and
monocytes and its down-regulation by lovastatin. Biochem Pharmacol.
57:383–386. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cominacini L, Rigoni A, Pasini AF, Garbin
U, Davoli A, Campagnola M, Pastorino AM, Lo Cascio V and Sawamura
T: The binding of oxidized low density lipoprotein (ox-LDL) to
ox-LDL receptor-1 reduces the intracellular concentration of nitric
oxide in endothelial cells through an increased production of
superoxide. J Biol Chem. 276:13750–13755. 2001.PubMed/NCBI
|
|
27
|
Apanay DC, Neylan JF, Ragab MS and Sgoutas
DS: Cyclosporine increases the oxidizability of low-density
lipoproteins in renal transplant recipients. Transplantation.
58:663–669. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leask A: Transcriptional profiling of the
scleroderma fibroblast reveals a potential role for connective
tissue growth factor (CTGF) in pathological fibrosis. Keio J Med.
53:74–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng O, Thuillier R, Sampson E, Schultz
G, Ruiz P, Zhang X, Yuen PS and Mannon RB: Connective tissue growth
factor is a biomarker and mediator of kidney allograft fibrosis. Am
J Transplant. 6:2292–2306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sohn M, Tan Y, Wang B, Klein RL,
Trojanowska M and Jaffa AA: Mechanisms of low-density
lipoprotein-induced expression of connective tissue growth factor
in human aortic endothelial cells. Am J Physiol Heart Circ Physiol.
290:H1624–H1634. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin S, Mathis AS, Rosenblatt J, Minko T,
Friedman GS, Gioia K, Serur DS and Knipp GT: Insights into
cyclosporine A-induced atherosclerotic risk in transplant
recipients: Macrophage scavenger receptor regulation.
Transplantation. 77:497–504. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Massy ZA: Hyperlipidemia and
cardiovascular disease after organ transplantation.
Transplantation. 72:S13–S15. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Varghese Z, Fernando RL, Turakhia G,
Psimenou E, Fernando ON, Sweny P, Powis SH and Moorhead JF:
Calcineurin inhibitors enhance low-density lipoprotein oxidation in
transplant patients. Kidney Int Suppl. 71:S137–S140. 1999.
View Article : Google Scholar : PubMed/NCBI
|
